OKEDI

This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug OKEDI contains one active pharmaceutical ingredient (API):

1 Risperidone UNII L6UH7ZF8HC - RISPERIDONE

Risperidone is a selective monoaminergic antagonist with unique properties. Although risperidone is a potent D2 antagonist, which is considered to improve the positive symptoms of schizophrenia, it causes less depression of motor activity and induction of catalepsy than classical antipsychotics. Read about Risperidone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OKEDI Powder and solvent for suspension for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AX08	Risperidone	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1875775, 1875786
Country: FR	Base de données publique des médicaments	Identifier(s): 62548690, 66633241
Country: IT	Agenzia del Farmaco	Identifier(s): 049966017, 049966029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1094268, 1094269
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100465940, 100467558
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68774001, W68775001